vs
FENNEC PHARMACEUTICALS INC.（FENC）与Research Solutions, Inc.（RSSS）财务数据对比。点击上方公司名可切换其他公司
FENNEC PHARMACEUTICALS INC.的季度营收约是Research Solutions, Inc.的1.2倍（$13.8M vs $11.8M），Research Solutions, Inc.净利率更高（4.6% vs -34.7%，领先39.4%），FENNEC PHARMACEUTICALS INC.同比增速更快（73.8% vs -1.0%），过去两年Research Solutions, Inc.的营收复合增速更高（-1.3% vs -26.3%）
Fennec制药是一家生物制药企业，专注于开发和商业化可降低儿童癌症患者治疗相关副作用的特种疗法，核心产品针对化疗引发的耳毒性，主要市场覆盖北美，服务肿瘤诊疗机构及儿童肿瘤患者群体。
雅各布斯解决方案是一家总部位于美国达拉斯的国际技术专业服务企业，面向全球各类客户（包括企业、机构及政府部门）提供工程、技术、专业、建筑相关服务，以及科研与专项咨询服务，常年位居《工程新闻纪录》顶级设计企业榜单榜首。
FENC vs RSSS — 直观对比
营收规模更大
FENC
是对方的1.2倍
$11.8M
营收增速更快
FENC
高出74.9%
-1.0%
净利率更高
RSSS
高出39.4%
-34.7%
两年增速更快
RSSS
近两年复合增速
-26.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $11.8M |
| 净利润 | $-4.8M | $546.9K |
| 毛利率 | — | 52.4% |
| 营业利润率 | -18.5% | 6.3% |
| 净利率 | -34.7% | 4.6% |
| 营收同比 | 73.8% | -1.0% |
| 净利润同比 | -141.1% | 127.6% |
| 每股收益（稀释后） | $-0.17 | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FENCRSSS
| Q4 25 | $13.8M | $11.8M | ||
| Q3 25 | $12.5M | $12.3M | ||
| Q2 25 | $9.7M | $12.4M | ||
| Q1 25 | $8.8M | $12.7M | ||
| Q4 24 | $7.9M | $11.9M | ||
| Q3 24 | $7.0M | $12.0M | ||
| Q2 24 | $7.3M | $12.1M | ||
| Q1 24 | $25.4M | $12.1M |
净利润FENCRSSS
| Q4 25 | $-4.8M | $546.9K | ||
| Q3 25 | $-638.0K | $749.4K | ||
| Q2 25 | $-3.2M | $2.4M | ||
| Q1 25 | $-1.2M | $216.5K | ||
| Q4 24 | $-2.0M | $-2.0M | ||
| Q3 24 | $-5.7M | $669.0K | ||
| Q2 24 | $-5.6M | $-2.8M | ||
| Q1 24 | $12.8M | $76.3K |
毛利率FENCRSSS
| Q4 25 | — | 52.4% | ||
| Q3 25 | — | 50.6% | ||
| Q2 25 | — | 51.0% | ||
| Q1 25 | — | 49.5% | ||
| Q4 24 | — | 48.9% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 46.5% | ||
| Q1 24 | — | 45.2% |
营业利润率FENCRSSS
| Q4 25 | -18.5% | 6.3% | ||
| Q3 25 | -1.5% | 7.8% | ||
| Q2 25 | -28.3% | 9.7% | ||
| Q1 25 | -9.2% | 4.4% | ||
| Q4 24 | -11.8% | 0.8% | ||
| Q3 24 | -74.6% | 5.4% | ||
| Q2 24 | -69.4% | 5.5% | ||
| Q1 24 | 54.2% | 0.7% |
净利率FENCRSSS
| Q4 25 | -34.7% | 4.6% | ||
| Q3 25 | -5.1% | 6.1% | ||
| Q2 25 | -32.7% | 19.0% | ||
| Q1 25 | -13.3% | 1.7% | ||
| Q4 24 | -25.0% | -16.6% | ||
| Q3 24 | -82.2% | 5.6% | ||
| Q2 24 | -76.5% | -23.3% | ||
| Q1 24 | 50.6% | 0.6% |
每股收益（稀释后）FENCRSSS
| Q4 25 | $-0.17 | $0.02 | ||
| Q3 25 | $-0.02 | $0.02 | ||
| Q2 25 | $-0.11 | $0.08 | ||
| Q1 25 | $-0.04 | $0.01 | ||
| Q4 24 | $-0.02 | $-0.07 | ||
| Q3 24 | $-0.21 | $0.02 | ||
| Q2 24 | $-0.20 | $-0.09 | ||
| Q1 24 | $0.41 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.8M | $12.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.5M | $17.2M |
| 总资产 | $70.6M | $44.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FENCRSSS
| Q4 25 | $36.8M | $12.3M | ||
| Q3 25 | $21.9M | $12.0M | ||
| Q2 25 | $18.7M | $12.2M | ||
| Q1 25 | $22.7M | $9.9M | ||
| Q4 24 | $26.6M | $7.7M | ||
| Q3 24 | $40.3M | $6.9M | ||
| Q2 24 | $43.1M | $6.1M | ||
| Q1 24 | $51.2M | $4.2M |
总债务FENCRSSS
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
股东权益FENCRSSS
| Q4 25 | $35.5M | $17.2M | ||
| Q3 25 | $-4.5M | $15.6M | ||
| Q2 25 | $-7.5M | $13.9M | ||
| Q1 25 | $-5.9M | $11.2M | ||
| Q4 24 | $-5.9M | $11.1M | ||
| Q3 24 | $-5.2M | $12.8M | ||
| Q2 24 | $-1.4M | $11.7M | ||
| Q1 24 | $3.0M | $14.1M |
总资产FENCRSSS
| Q4 25 | $70.6M | $44.2M | ||
| Q3 25 | $49.3M | $45.5M | ||
| Q2 25 | $44.9M | $46.1M | ||
| Q1 25 | $46.4M | $45.2M | ||
| Q4 24 | $44.9M | $42.8M | ||
| Q3 24 | $58.9M | $41.4M | ||
| Q2 24 | $63.2M | $41.9M | ||
| Q1 24 | $69.2M | $40.8M |
负债/权益比FENCRSSS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.0M | $1.4M |
| 自由现金流经营现金流 - 资本支出 | — | $1.4M |
| 自由现金流率自由现金流/营收 | — | 11.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | 2.53× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FENCRSSS
| Q4 25 | $-6.0M | $1.4M | ||
| Q3 25 | $1.5M | $1.1M | ||
| Q2 25 | $-3.7M | $2.3M | ||
| Q1 25 | $-4.3M | $2.9M | ||
| Q4 24 | $-1.5M | $1.0M | ||
| Q3 24 | $-2.2M | $843.1K | ||
| Q2 24 | $-8.4M | $2.0M | ||
| Q1 24 | $39.0M | $2.0M |
自由现金流FENCRSSS
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $2.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.9M | ||
| Q1 24 | — | $2.0M |
自由现金流率FENCRSSS
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 8.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 22.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 16.0% | ||
| Q1 24 | — | 16.6% |
资本支出强度FENCRSSS
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
现金转化率FENCRSSS
| Q4 25 | — | 2.53× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 0.96× | ||
| Q1 25 | — | 13.36× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | 26.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FENC
暂无分部数据
RSSS
| Transactions | $6.6M | 56% |
| Platforms | $5.2M | 44% |
